Chest Medicine
Study: Androgenetic Alopecia Present in the Majority of Hospitalized COVID-19 Patients
26 May, 2020 | 09:43h | UTC
Perspective: “Here’s What Needs to Happen Before We Can All Get Vaccinated for COVID-19”
26 May, 2020 | 09:45h | UTCHere’s what needs to happen before we can all get vaccinated for COVID-19 – CBC
WHO Pauses Hydroxychloroquine Arm Of COVID-19 Clinical Trial Due to Safety Concerns
26 May, 2020 | 09:35h | UTCSee also: WHO halts hydroxychloroquine trial for coronavirus amid safety fears – The Guardian AND WHO Halts Hydroxychloroquine Trial Over Safety Concerns – NPR
Remdesivir for the Treatment of Covid-19 — Preliminary Report
25 May, 2020 | 02:06h | UTCRemdesivir for the Treatment of Covid-19 — Preliminary Report – New England Journal of Medicine
Commentaries: Preliminary report on NIAID trial of remdesivir – PulmCrit AND Peer-reviewed data shows remdesivir for COVID-19 improves time to recovery – National Institutes of Health AND Covid-19 study details benefits of treatment with remdesivir, and also its limitations – STAT
Related Commentary on Twitter (Thread – Click for more)
I finished reading the Remdesivir trial
If you want my thoughts you will have to read this thread
[Thread] pic.twitter.com/GqA30lCOLI
— Vinay Prasad MD MPH (@VPrasadMDMPH) May 23, 2020
Perspective: The World May Be Overestimating the Power of Vaccines
25 May, 2020 | 01:55h | UTCThe world needs Covid-19 vaccines. It may also be overestimating their power – STAT
Hydroxychloroquine and Chloroquine for Covid-19: Large Observational Analysis Finds No Benefit and Possible Harm
25 May, 2020 | 02:03h | UTCCommentaries: Chloroquine or hydroxychloroquine for COVID-19: why might they be hazardous? – The Lancet AND What a big new study on malaria drugs as Covid-19 treatments tells us — and what it doesn’t – STAT AND Hydroxychloroquine May Cause More Harm Than Benefit To COVID-19 Patients, Says New Lancet Study – Health Policy Watch
Opinion: Why Countries Should Stop Using Anti-malarial Drugs for COVID-19
25 May, 2020 | 02:02h | UTCWhy countries should stop using anti-malarial drugs for COVID-19 – The Conversation
Editorial – SARS-CoV2 Vaccines: Slow is Fast
25 May, 2020 | 01:54h | UTCSARS-CoV2 vaccines: Slow is fast – Science
Promising Early Results with New Vaccine from China in Phase I Trial
25 May, 2020 | 01:57h | UTCCommentaries: First human trial of COVID-19 vaccine finds it is safe and induces rapid immune response – The Lancet AND Early Study Of Covid-19 Vaccine Developed In China Sees Mixed Results – Forbes AND Coronavirus Vaccine Shows Promising Early Results in China – The New York Times AND A Chinese biotech just published the first human data for its coronavirus vaccine candidate, supporting further trials – Business Insider AND Experts skeptical after researchers report positive vaccine results – CNN AND Two COVID-19 Vaccine Candidates Induce Immune Response In Healthy Volunteers – Health Policy Watch
Study: 10 of 60 Patients Treated for COVID-19 Persisted with Positive RT-PCR Results from 4 to 24 Days After Hospital Discharge
25 May, 2020 | 01:50h | UTCCommentaries: Expert reaction to study on PCR testing results from 60 people after clinical recovery from COVID-19 – Science Media Centre AND 16% of recovered patients test positive for COVID-19 weeks after discharge: study – UPI
Systematic Review: Ventilation Techniques and Risk for Transmission of Coronavirus Disease, Including COVID-19
25 May, 2020 | 01:40h | UTC
Meta-Analysis: Corticosteroids May Reduce Mortality for Patients with COVID-19 and ARDS
25 May, 2020 | 01:45h | UTC
Clinical Guidance: Thromboembolism and Anticoagulant Therapy During the COVID-19 Pandemic
25 May, 2020 | 01:43h | UTCRelated: Coagulation abnormalities and thrombosis in patients with COVID-19 – The Lancet AND COVID-19 and its implications for thrombosis and anticoagulation – Blood AND Prevention and Treatment of Venous Thromboembolism Associated with Coronavirus Disease 2019 Infection: A Consensus Statement before Guidelines – Thrombosis and Haemostasis AND Thrombosis and COVID-19: FAQs For Current Practice – American College of Cardiology
Cloth Masks May Prevent Transmission of COVID-19: An Evidence-Based, Risk-Based Approach
25 May, 2020 | 01:42h | UTC
Cohort Study: Prognostic Factors Associated with Adverse Outcomes Among Patients with Covid-19
25 May, 2020 | 01:35h | UTCEditorial: Covid-19 care before, during, and beyond the hospital
Commentary: Age, male sex, obesity, and underlying illness risk factors for severe COVID-19 or death – The BMJ
Choosing Wisely in the COVID-19 Era: Preventing Harm to Healthcare Workers
22 May, 2020 | 04:58h | UTC
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
22 May, 2020 | 04:59h | UTCCommentary: Lungs of deceased COVID-19 patients show distinctive features – Brigham and Women’s Hospital
Related: Postmortem Examination of Patients With COVID-19 – JAMA AND Pulmonary Arterial Thrombosis in COVID-19 With Fatal Outcome: Results From a Prospective, Single-Center, Clinicopathologic Case Series – Annals of Internal Medicine AND Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19 – Journal of Thrombosis and Haemostasis
How Coronavirus Lockdowns Stopped Flu in its Tracks
22 May, 2020 | 04:53h | UTCHow coronavirus lockdowns stopped flu in its tracks – Nature
“Reported rates of influenza and other infections have fallen sharply, but some communicable diseases may see a rise.”
15 Drugs Being Tested to Treat COVID-19 and How They Would Work
22 May, 2020 | 04:52h | UTC15 drugs being tested to treat COVID-19 and how they would work – Nature
[Preprint] IL6 Inhibition in Critically Ill COVID-19 Patients is Associated with Increased Secondary Infections
22 May, 2020 | 04:44h | UTC
Observational Study Suggests Possible Benefit from Early Short Course Corticosteroids in Hospitalized Patients with COVID-19
21 May, 2020 | 09:23h | UTCRelated: Study Commentary: Before/after Study of Short-Course Steroid in COVID-19
Olfactory Dysfunction in COVID-19: Diagnosis and Management
21 May, 2020 | 09:24h | UTCOlfactory Dysfunction in COVID-19: Diagnosis and Management – JAMA
Related: Loss of smell and taste as symptoms of COVID-19: what does the evidence say? – CEBM Oxford
Editorial: Unconventional Approaches to Mechanical Ventilation Through the COVID-19 Crisis
21 May, 2020 | 09:22h | UTC
[No Publication Available] Covid-19 Patients Testing Positive After Recovery Aren’t Infectious
20 May, 2020 | 10:00h | UTCCovid Patients Testing Positive After Recovery Aren’t Infectious, Study Shows – Bloomberg
Why Saliva Tests Could Offer a Better Alternative to Nasal COVID-19 Swabs
20 May, 2020 | 09:58h | UTCOriginal Article: Saliva—Friend and Foe in the COVID-19 Outbreak – Diagnostics